Eagleclaw Capital Managment Has Trimmed Apple (AAPL) Holding by $346,525; Stock Rose; As Amgen (AMGN) Shares Declined, Covington Capital Management Has Raised Its Stake by $435,370

August 12, 2018 - By Margaret Guttierez

Amgen Inc. (NASDAQ:AMGN) Logo

Covington Capital Management increased its stake in Amgen Inc (AMGN) by 5.97% based on its latest 2018Q1 regulatory filing with the SEC. Covington Capital Management bought 2,561 shares as the company’s stock declined 5.44% with the market. The institutional investor held 45,457 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $7.75 million, up from 42,896 at the end of the previous reported quarter. Covington Capital Management who had been investing in Amgen Inc for a number of months, seems to be bullish on the $125.84B market cap company. The stock increased 0.23% or $0.45 during the last trading session, reaching $194.42. About 1.52M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since August 12, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 23/04/2018 – Amgen at American Academy of Neurology Meeting Tomorrow; 30/04/2018 – AMGEN GETS POSITIVE CHMP OPINION TO ADD TOTAL SURVIVAL RESULTS; 26/04/2018 – ABBVIE INC – QTRLY GLOBAL HUMIRA SALES $4.71 BLN, UP 14.4 PCT ON REPORTED BASIS; 21/03/2018 – Adweek: Pharma Giant Amgen Sends Its Estimated $350 Million U.S. Media Business to Hearts & Science; 25/04/2018 – Sales of cholesterol medication Repatha more than doubled to $123 million, beating expectations; 23/03/2018 – AMGEN INC – RECOMMENDED LABEL INCLUDES NEW INDICATION BASED ON REPATHA CARDIOVASCULAR OUTCOMES STUDY; 06/03/2018 – AMGEN SAYS PRELIMINARY PRORATION FACTOR ABOUT 95.9%; 19/05/2018 – Egan Bernal Becomes First Colombian Amgen Tour of California Champion; Countryman Fernando Gaviria Sweeps Sprint Stages at; 21/05/2018 – FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis; 01/05/2018 – Regeneron and Sanofi to Lower Net Price of Praluent® (alirocumab) Injection in Exchange for Straightforward, More Affordable P

Eagleclaw Capital Managment Llc decreased its stake in Apple Inc (AAPL) by 3.41% based on its latest 2018Q1 regulatory filing with the SEC. Eagleclaw Capital Managment Llc sold 2,075 shares as the company’s stock rose 5.37% while stock markets declined. The institutional investor held 58,780 shares of the computer manufacturing company at the end of 2018Q1, valued at $9.87 million, down from 60,855 at the end of the previous reported quarter. Eagleclaw Capital Managment Llc who had been investing in Apple Inc for a number of months, seems to be less bullish one the $ market cap company. The stock decreased 0.30% or $0.62 during the last trading session, reaching $207.53. About 22.84 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 22.56% since August 12, 2017 and is uptrending. It has outperformed by 9.99% the S&P500. Some Historical AAPL News: 01/05/2018 – Apple accounts for 20 percent of Cognex revenues, according to Campling; 28/03/2018 – Goldman Sachs slashes Apple iPhone sales estimates due to ‘demand deterioration’; 16/05/2018 – Separately, The Washington Post reported on Wednesday that Virginia Gov. Ralph Northam has also floated areas near Washington D.C., like Crystal City and Tysons, as locales for Apple; 04/05/2018 – Warren Buffett’s Apple bet an ‘all-clear signal’ for investors: Art Cashin; 03/04/2018 – Boing Boing: Score Apple’s HomePod for free in this giveaway; 26/03/2018 – The CEOs of Apple and IBM think Facebook should see greater regulation in the wake of a data breach; 30/04/2018 – New York Post: Apple is rumored to be interested in Condé Nast; 17/04/2018 – Bank of America Goes for Biggest Maple Bond Offering Since Apple; 11/05/2018 – Harvard Adds Apple, Cuts Aduro Bio: 13F; 07/03/2018 – APPLE SAYS IT TRAINED 3M SUPPLIER WORKERS ON RIGHTS IN 2017

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on November, 1. They expect $2.75 EPS, up 32.85% or $0.68 from last year’s $2.07 per share. After $2.34 actual EPS reported by Apple Inc. for the previous quarter, Wall Street now forecasts 17.52% EPS growth.

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 36 have Buy rating, 1 Sell and 19 Hold. Therefore 64% are positive. Apple Inc. had 428 analyst reports since July 21, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, August 2 by Daiwa Securities. The firm earned “Buy” rating on Tuesday, July 25 by UBS. The stock has “Buy” rating by Canaccord Genuity on Friday, November 3. Canaccord Genuity maintained Apple Inc. (NASDAQ:AAPL) on Friday, September 16 with “Buy” rating. Piper Jaffray maintained Apple Inc. (NASDAQ:AAPL) on Thursday, November 30 with “Buy” rating. BMO Capital Markets maintained the shares of AAPL in report on Monday, July 23 with “Market Perform” rating. The firm has “Buy” rating given on Wednesday, April 27 by Maxim Group. The firm has “Buy” rating given on Wednesday, August 1 by Canaccord Genuity. The stock of Apple Inc. (NASDAQ:AAPL) earned “Buy” rating by HSBC on Wednesday, November 1. BTIG Research maintained it with “Buy” rating and $198.0 target in Tuesday, February 13 report.

Investors sentiment decreased to 0.69 in Q1 2018. Its down 0.04, from 0.73 in 2017Q4. It fall, as 69 investors sold AAPL shares while 1039 reduced holdings. 125 funds opened positions while 645 raised stakes. 2.86 billion shares or 3.74% less from 2.98 billion shares in 2017Q4 were reported. Valley Advisers stated it has 3.29% in Apple Inc. (NASDAQ:AAPL). Legg Mason Asset Management (Japan) Ltd invested in 21,200 shares or 2.51% of the stock. First Financial Bank Of Omaha has 2.62% invested in Apple Inc. (NASDAQ:AAPL) for 264,347 shares. Neumann Mgmt Ltd Llc holds 3.18% in Apple Inc. (NASDAQ:AAPL) or 29,810 shares. Rafferty Asset Management Limited Liability Company reported 0.03% of its portfolio in Apple Inc. (NASDAQ:AAPL). Lumina Fund Management Lc reported 2.95% of its portfolio in Apple Inc. (NASDAQ:AAPL). 3,865 are owned by Cutler Investment Counsel Ltd Llc. Pnc Fin Svcs Gp holds 8.85 million shares. Willis Investment Counsel accumulated 119,900 shares. Atwood & Palmer stated it has 2.81% in Apple Inc. (NASDAQ:AAPL). 22,670 are held by Wall Street Access Asset Mgmt Ltd Liability. Berson And Corrado Investment Advsrs invested 0.38% in Apple Inc. (NASDAQ:AAPL). Greenwich Wealth Ltd accumulated 65,435 shares. Hengehold Cap Mngmt Llc owns 3,873 shares. Alexandria Lc holds 2.22% or 89,332 shares in its portfolio.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Seekingalpha.com which released: “Free speech debate among Big Tech” on August 07, 2018, also Seekingalpha.com with their article: “Apple Gets Its Samsung Preview” published on August 09, 2018, Seekingalpha.com published: “If I Had A Trillion Dollars” on August 03, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Seekingalpha.com and their article: “Apple Delivers Solid Results” published on July 31, 2018 as well as Seekingalpha.com‘s news article titled: “2 Reasons To Hold Apple For 2 Years” with publication date: August 07, 2018.

Since April 3, 2018, it had 0 insider purchases, and 13 insider sales for $52.58 million activity. WILLIAMS JEFFREY E also sold $2.98 million worth of Apple Inc. (NASDAQ:AAPL) on Monday, July 9. On Wednesday, May 9 the insider LEVINSON ARTHUR D sold $6.51M. 38,228 shares were sold by AHRENDTS ANGELA J, worth $6.75M on Thursday, May 3. 69,491 shares valued at $11.56 million were sold by SCHILLER PHILIP W on Tuesday, April 3. On Wednesday, April 4 Riccio Daniel J. sold $2.94M worth of Apple Inc. (NASDAQ:AAPL) or 17,375 shares. 14,976 Apple Inc. (NASDAQ:AAPL) shares with value of $2.81M were sold by Srouji Johny.

Among 26 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 15 Hold. Therefore 42% are positive. Amgen Inc. had 95 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Friday, July 13 by Morgan Stanley. Morgan Stanley maintained Amgen Inc. (NASDAQ:AMGN) rating on Thursday, October 26. Morgan Stanley has “Overweight” rating and $193 target. As per Saturday, August 29, the company rating was maintained by Piper Jaffray. Robert W. Baird maintained the stock with “Neutral” rating in Monday, July 30 report. The firm earned “Outperform” rating on Friday, September 29 by Credit Suisse. As per Friday, February 2, the company rating was maintained by PiperJaffray. The rating was upgraded by Bank of America on Wednesday, February 1 to “Buy”. The stock has “Outperform” rating by Credit Suisse on Wednesday, January 20. The rating was initiated by Bernstein on Wednesday, June 29 with “Market Perform”. Jefferies maintained it with “Buy” rating and $200.0 target in Sunday, August 27 report.

Covington Capital Management, which manages about $1.97B and $1.52B US Long portfolio, decreased its stake in Vanguard World Fds (VGT) by 2,555 shares to 44,167 shares, valued at $7.55M in 2018Q1, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 3,564 shares in the quarter, leaving it with 35,453 shares, and cut its stake in Apple Inc (NASDAQ:AAPL).

Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.34, from 1.22 in 2017Q4. It worsened, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. State Farm Mutual Automobile Ins stated it has 0.75% in Amgen Inc. (NASDAQ:AMGN). 7,490 are held by Waters Parkerson And Ltd. Rowland Investment Counsel Adv holds 0% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 19,157 shares. Hm Payson & Communication holds 1.49% in Amgen Inc. (NASDAQ:AMGN) or 211,760 shares. Pr Herzig reported 13,170 shares. Gilman Hill Asset Limited Liability Corp invested in 4,967 shares. Finance Counselors has 90,360 shares for 0.73% of their portfolio. Pitcairn reported 5,666 shares. Churchill reported 0.51% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Of Toledo Na Oh has 0.46% invested in Amgen Inc. (NASDAQ:AMGN) for 10,118 shares. Old Second State Bank Of Aurora accumulated 234 shares. First Merchants owns 13,072 shares or 0.37% of their US portfolio. Homrich Berg invested in 1,332 shares or 0.02% of the stock. Etrade Capital Management Lc invested 0.06% in Amgen Inc. (NASDAQ:AMGN). Papp L Roy & Associates reported 13,474 shares.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts